13 BSE 500 Stocks Record FiveDay Losing Streak Amid Broader Market Resilience Security Incident Near White House Raises Geopolitical Concerns Kevin Warsh Faces Potential Policy Challenges as Fed Grapples with Inflation and Rising Yields Unretirement Trend More Older Americans Rejoin Workforce for Financial and Personal Reasons SpaceX OpenAI Anthropic FirstDay Valuations Could Exceed Berkshire Hathaway Polymarket Shows Slow Food Movement Founder Carlo Petrini Dies at 76 Leaving Legacy in Sustainable Food Sector FiscalNote Q1 2026 Earnings EPS Surprise Beats Estimates Despite Stock Decline Qorvo Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction EICC Q4 2025 Earnings Marginal EPS Miss Amid Stable Preferred Stock Performance Coinbase Q1 2026 Earnings Deep Losses on Revenue Miss and Regulatory Overhang XRTX Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue RD Costs Shares Climb PHAR Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower Sky Quarry Inc SKYQ Slides 36 as Selling Pressure Tests Key Support Zone Agriculture Natural Solutions Acquisition Warrant ANSCW Holds Flat at 023 Amid Low Volume BP Shares Decline Over 2 as Energy Sector Faces Headwinds Support Levels in Focus Advanced Biomed Inc ADVB Faces Pressure as Shares Retreat Over 2 Centurion Acquisition Corp Warrant ALFUW Holds Steady at 014 as Support and Resistance Levels Tighten SpaceX Successfully Launches Starship on Second Attempt in Key Test Flight Teleflex Q1 2026 Earnings EPS Beats Estimates by 14 as Company Maintains Steady Performance Doximity Inc DOCS Holds Near Support After Modest Decline South Korea Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Unrest SP 500 Edges Higher as Healthcare and Tech Lead Communications Drag Inflation Pinch Intensifies for US Consumers Ahead of Memorial Day Weekend Cornwalls Nansledan Development A Retail Blueprint or a Threat to Newquays High Street Guardian Investigation Reveals Asbestos Contamination in Toys Sold in Britain Spotlighting Regulatory Gaps Oppenheimer Maintains Outperform Rating on Gain Therapeutics Signaling Continued Confidence Prediction Market Investments Persist Despite Regulatory Uncertainty